Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic Dermatitis

NCT01320579 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Cis-UCA 2.5% emulsion cream
DRUG: Cis-UCA 5% emulsion cream
DRUG: Placebo for cis-UCA emulsion cream
DRUG: Protopic® 0.1% ointment

Sponsor

BioCis Pharma Ltd